The COCOA-PAD II Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 190 participants.

Also called NCT04794530

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 190 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04794530
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04794530. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-19 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The COCOA-PAD II Trial
Acronym
COCOA-PAD II
Condition
Peripheral Artery Disease
Intervention (Drug)
cocoa flavanols
Intervention (Drug)
placebo
Lead sponsor
Northwestern University (class: other)
Collaborator
National Institute on Aging (NIA) (class: US National Institutes of Health)
Collaborator
University of Minnesota (class: other)
Collaborator
University of Chicago (class: other)

Record details

Record id
cardio:ct-nct04794530
Content hash
a0e5a8a9525247ba44c7f94c65ce25f36f057955f7c5d67b3e7d4194e35161c7